Solventum Future Growth
Future criteria checks 1/6
Solventum's earnings are forecast to decline at 13.9% per annum while its annual revenue is expected to grow at 0.8% per year. EPS is expected to decline by 15.5% per annum. Return on equity is forecast to be 22.4% in 3 years.
Key information
-13.9%
Earnings growth rate
-15.5%
EPS growth rate
| Medical Equipment earnings growth | 17.5% |
| Revenue growth rate | 0.8% |
| Future return on equity | 22.4% |
| Analyst coverage | Good |
| Last updated | 12 Sep 2024 |
Recent future growth updates
Recent updates
Solventum: No Rush To Buy As Post-Spin Execution Will Take Time To Play Out
Sep 11Solventum (NYSE:SOLV) Has A Pretty Healthy Balance Sheet
Aug 18
Solventum: Stumbling Out Of The Gate
Jul 07Solventum Corporation (NYSE:SOLV) Shares Could Be 27% Below Their Intrinsic Value Estimate
Jun 26Solventum: A Reasonable Start, Still Some Questions To Be Asked
May 173M Says Bye To Solventum - Why I Stick To My Bullish Call
Apr 02Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 8,416 | 759 | 1,048 | 1,312 | 5 |
| 12/31/2025 | 8,240 | 765 | 899 | 1,230 | 7 |
| 12/31/2024 | 8,201 | 854 | 757 | 1,295 | 6 |
| 6/30/2024 | 8,207 | 1,058 | 1,523 | 1,837 | N/A |
| 3/31/2024 | 8,202 | 1,290 | 1,521 | 1,848 | N/A |
| 12/31/2023 | 8,197 | 1,346 | 1,625 | 1,915 | N/A |
| 9/30/2023 | 8,166 | 1,381 | 1,530 | 1,814 | N/A |
| 6/30/2023 | 8,101 | 1,256 | 1,542 | 1,817 | N/A |
| 3/31/2023 | 8,083 | 1,286 | 1,560 | 1,820 | N/A |
| 12/31/2022 | 8,130 | 1,343 | 1,428 | 1,679 | N/A |
| 12/31/2021 | 8,171 | 1,460 | 1,925 | 2,202 | N/A |
| 12/31/2020 | 7,281 | 1,138 | 1,755 | 2,026 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SOLV's earnings are forecast to decline over the next 3 years (-13.9% per year).
Earnings vs Market: SOLV's earnings are forecast to decline over the next 3 years (-13.9% per year).
High Growth Earnings: SOLV's earnings are forecast to decline over the next 3 years.
Revenue vs Market: SOLV's revenue (0.8% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: SOLV's revenue (0.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SOLV's Return on Equity is forecast to be high in 3 years time (22.4%)